PRELUDE THERAPEUTICS INC Proceeds from Stock Options Exercised
PRELUDE THERAPEUTICS INC (PRLD) reported Proceeds from Stock Options Exercised of $116.00 thousand for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-11.
Financial Statements › Cash Flow › Financing Activities
us-gaap:ProceedsFromStockOptionsExercised · last filed 2026-08-11
- PRELUDE THERAPEUTICS INC proceeds from stock options exercised for the quarter ending 2026-06-30 was $85.00K.
- PRELUDE THERAPEUTICS INC proceeds from stock options exercised for the quarter ending 2026-03-31 was $31.00K.
- PRELUDE THERAPEUTICS INC proceeds from stock options exercised for the quarter ending 2025-12-31 was $16.00K.
- PRELUDE THERAPEUTICS INC proceeds from stock options exercised for the quarter ending 2025-09-30 was $0.00, a 100.00% decline year-over-year.
- PRELUDE THERAPEUTICS INC proceeds from stock options exercised for fiscal 2025 was $16.00K, a 73.33% decline from fiscal 2024.
- PRELUDE THERAPEUTICS INC proceeds from stock options exercised for fiscal 2024 was $60.00K, a 27.66% increase from fiscal 2023.
- PRELUDE THERAPEUTICS INC proceeds from stock options exercised for fiscal 2023 was $47.00K, a 87.92% decline from fiscal 2022.
- PRELUDE THERAPEUTICS INC proceeds from stock options exercised for fiscal 2022 was $389.00K, a 88.90% decline from fiscal 2021.
| Period end | Proceeds from Stock Options Exercised 3 month | Proceeds from Stock Options Exercised 6 month | Proceeds from Stock Options Exercised 9 month | Proceeds from Stock Options Exercised 12 month |
|---|---|---|---|---|
| 2026-06-30 | $85.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-11 | $116.00K 10-Q · filed 2026-08-11 | $132.00K derived: sum of 3 quarters · filed 2026-08-11 | $132.00K derived: sum of 4 quarters · filed 2026-08-11 |
| 2026-03-31 | $31.00K 10-Q · filed 2026-05-12 | $47.00K derived: sum of 2 quarters · filed 2026-05-12 | $47.00K derived: sum of 3 quarters · filed 2026-05-12 | $47.00K derived: sum of 4 quarters · filed 2026-08-11 |
| 2025-12-31 | $16.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-10 | $16.00K derived: sum of 2 quarters · filed 2026-03-10 | $16.00K derived: sum of 3 quarters · filed 2026-08-11 | $16.00K 10-K · filed 2026-03-10 |
| 2025-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-12 | $0.00 derived: sum of 2 quarters · filed 2026-08-11 | $0.00 10-Q · filed 2025-11-12 | $0.00 derived: sum of 4 quarters · filed 2026-08-11 |
| 2025-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-11 | $0.00 10-Q · filed 2026-08-11 | $0.00 derived: sum of 3 quarters · filed 2026-08-11 | $56.00K derived: sum of 4 quarters · filed 2026-08-11 |
| 2025-03-31 | $0.00 10-Q · filed 2026-05-12 | $0.00 derived: sum of 2 quarters · filed 2026-05-12 | $56.00K derived: sum of 3 quarters · filed 2026-05-12 | $58.00K derived: sum of 4 quarters · filed 2026-05-12 |
| 2024-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-10 | $56.00K derived: sum of 2 quarters · filed 2026-03-10 | $58.00K derived: sum of 3 quarters · filed 2026-03-10 | $60.00K 10-K · filed 2026-03-10 |
| 2024-09-30 | $56.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-12 | $58.00K derived: sum of 2 quarters · filed 2025-11-12 | $60.00K 10-Q · filed 2025-11-12 | $76.00K derived: sum of 4 quarters · filed 2025-11-12 |
| 2024-06-30 | $2.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-14 | $4.00K 10-Q · filed 2025-08-14 | $20.00K derived: sum of 3 quarters · filed 2025-08-14 | $20.00K derived: sum of 4 quarters · filed 2025-08-14 |
| 2024-03-31 | $2.00K 10-Q · filed 2025-05-06 | $18.00K derived: sum of 2 quarters · filed 2025-05-06 | $18.00K derived: sum of 3 quarters · filed 2025-05-06 | $21.00K derived: sum of 4 quarters · filed 2025-05-06 |
| 2023-12-31 | $16.00K derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-10 | $16.00K derived: sum of 2 quarters · filed 2025-03-10 | $19.00K derived: sum of 3 quarters · filed 2025-03-10 | $47.00K 10-K · filed 2025-03-10 |
| 2023-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-06 | $3.00K derived: sum of 2 quarters · filed 2024-11-06 | $31.00K 10-Q · filed 2024-11-06 | $60.00K derived: sum of 4 quarters · filed 2024-11-06 |
| 2023-06-30 | $3.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-12 | $31.00K 10-Q · filed 2024-08-12 | $60.00K derived: sum of 3 quarters · filed 2024-08-12 | $208.00K derived: sum of 4 quarters · filed 2024-08-12 |
| 2023-03-31 | $28.00K 10-Q · filed 2024-05-07 | $57.00K derived: sum of 2 quarters · filed 2024-05-07 | $205.00K derived: sum of 3 quarters · filed 2024-05-07 | $264.00K derived: sum of 4 quarters · filed 2024-05-07 |
| 2022-12-31 | $29.00K derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-15 | $177.00K derived: sum of 2 quarters · filed 2024-02-15 | $236.00K derived: sum of 3 quarters · filed 2024-02-15 | $389.00K 10-K · filed 2024-02-15 |
| 2022-09-30 | $148.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-01 | $207.00K derived: sum of 2 quarters · filed 2023-11-01 | $360.00K 10-Q · filed 2023-11-01 | $2.35M derived: sum of 4 quarters · filed 2023-11-01 |
| 2022-06-30 | $59.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-03 | $212.00K 10-Q · filed 2023-08-03 | $2.20M derived: sum of 3 quarters · filed 2023-08-03 | $2.91M derived: sum of 4 quarters · filed 2023-08-03 |
| 2022-03-31 | $153.00K 10-Q · filed 2023-05-08 | $2.14M derived: sum of 2 quarters · filed 2023-05-08 | $2.85M derived: sum of 3 quarters · filed 2023-05-08 | $3.27M derived: sum of 4 quarters · filed 2023-05-08 |
| 2021-12-31 | $1.99M derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-15 | $2.70M derived: sum of 2 quarters · filed 2023-03-15 | $3.12M derived: sum of 3 quarters · filed 2023-03-15 | $3.50M 10-K · filed 2023-03-15 |
| 2021-09-30 | $711.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-14 | $1.13M derived: sum of 2 quarters · filed 2022-11-14 | $1.52M 10-Q · filed 2022-11-14 | $1.52M derived: sum of 4 quarters · filed 2022-11-14 |
| 2021-06-30 | $422.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-09 | $808.00K 10-Q · filed 2022-08-09 | $812.00K derived: sum of 3 quarters · filed 2022-08-09 | $877.00K derived: sum of 4 quarters · filed 2022-08-09 |
| 2021-03-31 | $386.00K 10-Q · filed 2022-05-10 | $390.00K derived: sum of 2 quarters · filed 2022-05-10 | $455.00K derived: sum of 3 quarters · filed 2022-05-10 | |
| 2020-12-31 | $4.00K derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-17 | $69.00K derived: sum of 2 quarters · filed 2022-03-17 | $100.00K 10-K · filed 2022-03-17 | |
| 2020-09-30 | $65.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-12 | $96.00K 10-Q · filed 2021-11-12 | ||
| 2020-06-30 | $31.00K 10-Q · filed 2021-08-12 | |||
| 2019-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-16 | $5.00K 10-K · filed 2021-03-16 | ||
| 2019-09-30 | $5.00K 10-Q · filed 2020-11-10 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Evommune, Inc. (EVMN) | United States | $0.320B | -5.10 |
| BridgeBio Oncology Therapeutics, Inc. (BBOT) | United States | $0.320B | -3.35 |
| ABEONA THERAPEUTICS INC. (ABEO) | United States | $0.312B | -5.63 |
| GT Biopharma, Inc. (GTBP) | United States | $0.309B | -4.58 |
| BioAge Labs, Inc. (BIOA) | United States | $0.333B | -11.88 |
| Vanda Pharmaceuticals Inc. (VNDA) | United States | $0.302B | -1.35 |
| Benitec Biopharma Inc. (BNTC) | United States | $0.337B | -10.08 |
| STANDARD BIOTOOLS INC. (LAB) | United States | $0.297B | 3.80 |
| ROCKET PHARMACEUTICALS, INC. (RCKT) | United States | $0.296B | -21.78 |
| Larimar Therapeutics, Inc. (LRMR) | United States | $0.344B | -1.83 |